This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (1249)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Findings in 356 222 Primary Screenees of the Multiple Risk Factor Intervention Trial (MRFIT)

Jeremiah Stamler, MD; Deborah Wentworth, MPH; James D. Neaton, PhD

JAMA. 1986;256(20):2823-2828.

Abstract
The 356 222 men aged 35 to 57 years, who were free of a history of hospitalization for myocardial infarction, screened by the Multiple Risk Factor Intervention Trial (MRFIT) in its recruitment effort, constitute the largest cohort with standardized serum cholesterol measurements and long-term mortality follow-up. For each five-year age group, the relationship between serum cholesterol and coronary heart disease (CHD) death rate was continuous, gradecf, and strong. For the entire group aged 35 to 57 years at entry, the age-adjusted risks of CHD death in cholesterol quintiles 2 through 5 (182 to 202, 203 to 220, 221 to 244, and 245 mg/dL [4.71 to 5.22, 5.25 to 5.69, 5.72 to 6.31, and 6.34 mmol/L]) relative to the lowest quintile were 1.29, 1.73, 2.21, and 3.42. Of all CHD deaths, 46% were estimated to be excess deaths attributable to serum cholesterol levels 180 mg/dL or greater (4.65 mmol/L), with almost half the excess deaths in serum cholesterol quintiles 2 through 4. The pattern of a continuous, graded, strong relationship between serum cholesterol and six-year age-adjusted CHD death rate prevailed for nonhypertensive nonsmokers, nonhypertensive smokers, hypertensive nonsmokers, and hypertensive smokers. These data of high precision show that the relationship between serum cholesterol and CHD is not a threshold one, with increased risk confined to the two highest quintiles, but rather is a continuously graded one that powerfully affects risk for the great majority of middle-aged American men.

(JAMA 1986;256:2823-2828)

Author Affiliations
for the MRFIT Research Group

From the MRFIT Coordinating Center, University of Minnesota, Minneapolis.

Footnotes
Reprint requests to MRFIT Coordinating Center, University of Minnesota, 2829 University Ave SE, Suite 508, Minneapolis, MN 55414-3270 (Ms Wentworth).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Relations of Lipid Concentrations to Heart Failure Incidence: The Framingham Heart Study
Velagaleti et al.
Circulation 2009;120:2345-2351.
ABSTRACT | FULL TEXT  

American Diabetes Association Indications for Statins in Diabetes: Is there evidence?
Eldor and Raz
Diabetes Care 2009;32:S384-S391.
FULL TEXT  

Living longer and feeling better: healthy lifestyle, self-rated health, obesity and depression in Ireland
Harrington et al.
Eur J Public Health 2009;0:ckp102v2-ckp102.
ABSTRACT | FULL TEXT  

A Common Variant in Low-Density Lipoprotein Receptor-Related Protein 6 Gene (LRP6) Is Associated With LDL-Cholesterol
Tomaszewski et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:1316-1321.
ABSTRACT | FULL TEXT  

Dyslipidemia and Risk of Coronary Heart Disease: Role of Lifestyle Approaches for Its Management
Leon and Bronas
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2009;3:257-273.
ABSTRACT  

Lifestyle Interventions Reduce Coronary Heart Disease Risk: Results From the PREMIER Trial
Maruthur et al.
Circulation 2009;119:2026-2031.
ABSTRACT | FULL TEXT  

LDL Cholesterol and the Development of Stroke Subtypes and Coronary Heart Disease in a General Japanese Population: The Hisayama Study
Imamura et al.
Stroke 2009;40:382-388.
ABSTRACT | FULL TEXT  

CHAPTER 13 Hypertension
Kjeldsen et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT | FULL TEXT  

Review: Hypercholesterolemia-associated endothelial progenitor cell dysfunction
Pirro et al.
Ther Adv Cardiovasc Dis 2008;2:329-339.
ABSTRACT  

The Multiple Risk Factor Intervention Trial (MRFIT)--Importance Then and Now
Stamler and Neaton
JAMA 2008;300:1343-1345.
FULL TEXT  

Hypercholesterolaemia and its management
Bhatnagar et al.
BMJ 2008;337:a993-a993.
FULL TEXT  

Traditional Risk Factors Are Predictive on Segmental Localization of Coronary Artery Disease
Tacoy et al.
ANGIOLOGY 2008;59:402-407.
ABSTRACT  

Cigarette Smoking, Systolic Blood Pressure, and Cardiovascular Diseases in the Asia-Pacific Region
Nakamura et al.
Stroke 2008;39:1694-1702.
ABSTRACT | FULL TEXT  

A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor
Grundy
Eur Heart J Suppl 2008;10:B16-B23.
ABSTRACT | FULL TEXT  

State of the Art Reviews: Relationship Between Diet/ Physical Activity and Health
O'Neil and Nicklas
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2007;1:457-481.
ABSTRACT  

Cholesterol Fractions and Apolipoproteins as Risk Factors for Heart Disease Mortality in Older Men
Clarke et al.
Arch Intern Med 2007;167:1373-1378.
ABSTRACT | FULL TEXT  

The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs
Nogueira and Weir
CJASN 2007;2:766-785.
ABSTRACT | FULL TEXT  

Plasma LDL and HDL Cholesterol and Oxidized LDL Concentrations Are Altered in Normo- and Hypercholesterolemic Humans after Intake of Different Levels of Cocoa Powder
Baba et al.
J. Nutr. 2007;137:1436-1441.
ABSTRACT | FULL TEXT  

Statins: Targeting Inflammation by Lowering Low-Density Lipoprotein?
Tuzcu and Nicholls
J Am Coll Cardiol 2007;49:2010-2012.
FULL TEXT  

A High-Fat Meal Increases Cardiovascular Reactivity to Psychological Stress in Healthy Young Adults
Jakulj et al.
J. Nutr. 2007;137:935-939.
ABSTRACT | FULL TEXT  

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis
Nicholls et al.
JAMA 2007;297:499-508.
ABSTRACT | FULL TEXT  

Intake of Fish Oil, Oleic Acid, Folic Acid, and Vitamins B-6 and E for 1 Year Decreases Plasma C-Reactive Protein and Reduces Coronary Heart Disease Risk Factors in Male Patients in a Cardiac Rehabilitation Program
Carrero et al.
J. Nutr. 2007;137:384-390.
ABSTRACT | FULL TEXT  

The Rationale for Intervention to Reduce the Risk of Coronary Heart Disease
Rippe et al.
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2007;1:10-19.
ABSTRACT  

Combined Organ Failure with Combination Antihyperlipidemic Treatment: A Case of Hepatic Injury and Acute Renal Failure
Akoglu et al.
The Annals of Pharmacotherapy 2007;41:143-147.
ABSTRACT | FULL TEXT  

Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors
Roberts et al.
J. Appl. Physiol. 2006;101:1727-1732.
ABSTRACT | FULL TEXT  

A Combination Therapy Including Psyllium and Plant Sterols Lowers LDL Cholesterol by Modifying Lipoprotein Metabolism in Hypercholesterolemic Individuals
Shrestha et al.
J. Nutr. 2006;136:2492-2497.
ABSTRACT | FULL TEXT  

Cholesterol Primes Vascular Smooth Muscle to Induce Ca2 Sensitization Mediated by a Sphingosylphosphorylcholine-Rho-Kinase Pathway: Possible Role for Membrane Raft
Morikage et al.
Circ. Res. 2006;99:299-306.
ABSTRACT | FULL TEXT  

A tale of three species rabbits, chickens and humans: an interview with clinical trials pioneer Jeremiah Stamler
Wittes
Clin Trials 2006;3:320-334.
 

Role of the Pharmacist in the Management of Dyslipidemia
Olson and Potts
Journal of Pharmacy Practice 2006;19:94-102.
ABSTRACT  

Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui and Mallat
Physiol. Rev. 2006;86:515-581.
ABSTRACT | FULL TEXT  

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
Cohen et al.
NEJM 2006;354:1264-1272.
ABSTRACT | FULL TEXT  

Managing Abnormal Blood Lipids: A Collaborative Approach
Fletcher et al.
Circulation 2005;112:3184-3209.
ABSTRACT | FULL TEXT  

Intensive Lipid-Lowering Therapy in Patients with Coronary Heart Disease
Lauderdale and Sheehan
The Annals of Pharmacotherapy 2005;39:329-334.
ABSTRACT | FULL TEXT  

Effects of exercise and diet on chronic disease
Roberts and Barnard
J. Appl. Physiol. 2005;98:3-30.
ABSTRACT | FULL TEXT  

Hyperlipidemic Subjects Have Reduced Uptake of Newly Absorbed Vitamin E into Their Plasma Lipoproteins, Erythrocytes, Platelets, and Lymphocytes, as Studied by Deuterium-Labeled {alpha}-Tocopherol Biokinetics
Hall et al.
J. Nutr. 2005;135:58-63.
ABSTRACT | FULL TEXT  

Pathogenesis of Atherosclerosis
Crowther
ASH Education Book 2005;2005:436-441.
ABSTRACT | FULL TEXT  

Serum Lipid Concentrations and Prevalence of Dyslipidemia in a Large Professional Population in Beijing
Li et al.
Clin. Chem. 2005;51:144-150.
ABSTRACT | FULL TEXT  

A Cluster of Metabolic Defects Caused by Mutation in a Mitochondrial tRNA
Wilson et al.
Science 2004;306:1190-1194.
ABSTRACT | FULL TEXT  

Intensive treatment with statins and the progression of cardiovascular diseases: the beginning of a new era?
Tunon et al.
Nephrol Dial Transplant 2004;19:2696-2699.
FULL TEXT  

Dietary cholesterol does not increase biomarkers for chronic disease in a pediatric population from northern Mexico
Ballesteros et al.
Am. J. Clin. Nutr. 2004;80:855-861.
ABSTRACT | FULL TEXT  

Cardiology management improves secondary prevention measures among patients with coronary artery disease
Ho et al.
J Am Coll Cardiol 2004;43:1517-1523.
ABSTRACT | FULL TEXT  

The Hunter-Gatherer Diet-Reply-I
Cordain and O'Keefe
Mayo Clin Proc. 2004;79:703-707.
 

Pharmacologic Lipid-Lowering Therapy in Type 2 Diabetes Mellitus: Background Paper for the American College of Physicians
Vijan and Hayward
ANN INTERN MED 2004;140:650-658.
ABSTRACT | FULL TEXT  

Statins for primary prevention: strategic options to save lives and money
Shepherd
JRSM 2004;97:66-71.
FULL TEXT  

Relation Between Progression and Regression of Atherosclerotic Left Main Coronary Artery Disease and Serum Cholesterol Levels as Assessed With Serial Long-Term (>=12 Months) Follow-Up Intravascular Ultrasound
von Birgelen et al.
Circulation 2003;108:2757-2762.
ABSTRACT | FULL TEXT  

The use of cholesterol-lowering medications after coronary revascularization
Brophy et al.
CMAJ 2003;169:1153-1157.
ABSTRACT | FULL TEXT  

Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias
Emberson et al.
Eur Heart J 2003;24:1719-1726.
ABSTRACT | FULL TEXT  

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor
Boger
Cardiovasc Res 2003;59:824-833.
ABSTRACT | FULL TEXT  

Are lipid-lowering drugs also antiarrhythmic drugs?: an analysis of the antiarrhythmics versus implantable defibrillators (AVID) trial
Mitchell et al.
J Am Coll Cardiol 2003;42:81-87.
ABSTRACT | FULL TEXT  

Effects of dietary monounsaturated fatty acids on lipoprotein concentrations, compositions, and subfraction distributions and on VLDL apolipoprotein B kinetics: dose-dependent effects on LDL
Gill et al.
Am. J. Clin. Nutr. 2003;78:47-56.
ABSTRACT | FULL TEXT  

Practical issues around putting the patient at the centre of care
Dunn
JRSM 2003;96:325-327.
FULL TEXT  

Aggressive Lipid Management for Cardiovascular Prevention: Evidence from Clinical Trials
Friday
Exp. Biol. Med. 2003;228:769-778.
ABSTRACT | FULL TEXT  

Low-density lipoprotein cholesterol targets in 2003
Faergeman
Eur Heart J Suppl 2003;5:D3-D7.
ABSTRACT  

Relationship of Peripheral Arterial Compliance and Standard Cardiovascular Risk Factors
Willens et al.
VASC ENDOVASCULAR SURG 2003;37:197-206.
ABSTRACT  

References
Circulation 2002;106:3373-3421.
FULL TEXT  

Cost-effectiveness of a family and DNA based screening programme on familial hypercholesterolaemia in The Netherlands
Marang-van de Mheen et al.
Eur Heart J 2002;23:1922-1930.
ABSTRACT  

The search for new risk factors for coronary heart disease: occupational therapy for epidemiologists?
Beaglehole and Magnus
Int J Epidemiol 2002;31:1117-1122.
ABSTRACT | FULL TEXT  

1-[4-[4[(4R,5R)-3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]butyl]-4-aza-1-azoniabicyclo[2.2.2]octane Methanesulfonate (SC-435), an Ileal Apical Sodium-Codependent Bile Acid Transporter Inhibitor Alters Hepatic Cholesterol Metabolism and Lowers Plasma Low-Density Lipoprotein-Cholesterol Concentrations in Guinea Pigs
West et al.
J. Pharmacol. Exp. Ther. 2002;303:293-299.
ABSTRACT | FULL TEXT  

Cardiovascular Disease Risk Factors Are Related to Adult Adiposity but Not Birth Weight in Young Guatemalan Adults
Stein et al.
J. Nutr. 2002;132:2208-2214.
ABSTRACT | FULL TEXT  

Risk factor thresholds: their existence under scrutiny
Law and Wald
BMJ 2002;324:1570-1576.
FULL TEXT  

Pre-Menopausal Women, Classified as Hypo- or Hyper-Responders, do not Alter their LDL/HDL Ratio Following a High Dietary Cholesterol Challenge
Herron et al.
J. Am. Coll. Nutr. 2002;21:250-258.
ABSTRACT | FULL TEXT  

Balancing Life-Style and Genomics Research for Disease Prevention
Willett
Science 2002;296:695-698.
ABSTRACT | FULL TEXT  

Screening for traditional risk factors for cardiovascular disease: A review for oral health care providers
GLICK
Journal of the American Dental Association 2002;133:291-300.
ABSTRACT | FULL TEXT  

Obstructive Sleep Apnea Is Independently Associated with Insulin Resistance
IP et al.
Am. J. Respir. Crit. Care Med. 2002;165:670-676.
ABSTRACT | FULL TEXT  

Corn Fiber Oil Lowers Plasma Cholesterol by Altering Hepatic Cholesterol Metabolism and Up-Regulating LDL Receptors in Guinea Pigs
Ramjiganesh et al.
J. Nutr. 2002;132:335-340.
ABSTRACT | FULL TEXT  

New Tools for Coronary Risk Assessment: What Are Their Advantages and Limitations?
Pearson
Circulation 2002;105:886-892.
ABSTRACT | FULL TEXT  

Relation of Cigarette Smoking to 25-Year Mortality in Middle-aged Men with Low Baseline Serum Cholesterol : The Chicago Heart Association Detection Project in Industry
Blanco-Cedres et al.
Am J Epidemiol 2002;155:354-360.
ABSTRACT | FULL TEXT  

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project
Simes et al.
Eur Heart J 2002;23:207-215.
ABSTRACT  

Lipids and Atherosclerosis: Lessons Learned from Randomized Controlled Trials of Lipid Lowering and Other Relevant Studies
Kreisberg and Oberman
J. Clin. Endocrinol. Metab. 2002;87:423-437.
FULL TEXT  

How best to combat the enemies? Lipid lowering
Cobbe
Eur Heart J Suppl 2002;4:A48-A52.
ABSTRACT  

The Real Contribution of the Major Risk Factors to the Coronary Epidemics: Time to End the "Only-50%" Myth
Magnus and Beaglehole
Arch Intern Med 2001;161:2657-2660.
FULL TEXT  

Myocardial Infarction in Young Adults With Low-Density Lipoprotein Cholesterol Levels <= 100 mg/dL : Clinical Profile and 1-Year Outcomes
Akosah et al.
Chest 2001;120:1953-1958.
ABSTRACT | FULL TEXT  

Coronary Artery Calcification in Older Adults to Age 99: Prevalence and Risk Factors
Newman et al.
Circulation 2001;104:2679-2684.
ABSTRACT | FULL TEXT  

Global Burden of Cardiovascular Diseases: Part I: General Considerations, the Epidemiologic Transition, Risk Factors, and Impact of Urbanization
Yusuf et al.
Circulation 2001;104:2746-2753.
ABSTRACT | FULL TEXT  

Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I
Shah et al.
Circulation 2001;104:2376-2383.
FULL TEXT  

Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy
McGladdery and Frohlich
J. Lipid Res. 2001;42:1905-1912.
ABSTRACT | FULL TEXT  

Lipid Disorders : Justification of Methods and Goals of Treatment
Braunstein et al.
Chest 2001;120:979-988.
ABSTRACT | FULL TEXT  

Temporal Trends (1986-1997) in Cholesterol Level Assessment and Management Practices in Patients With Acute Myocardial Infarction: A Population-Based Perspective
Yarzebski et al.
Arch Intern Med 2001;161:1521-1528.
ABSTRACT | FULL TEXT  

The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects
de Roos et al.
Am. J. Clin. Nutr. 2001;73:45-52.
ABSTRACT | FULL TEXT  

Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events
van Lennep et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:2408-2413.
ABSTRACT | FULL TEXT  

A Reference Method Laboratory Network for Cholesterol: A Model for Standardization and Improvement of Clinical Laboratory Measurements
Myers et al.
Clin. Chem. 2000;46:1762-1772.
ABSTRACT | FULL TEXT  

"The Lower the Better" in Hypercholesterolemia Therapy: A Reliable Clinical Guideline?
Jacobson
ANN INTERN MED 2000;133:549-554.
ABSTRACT | FULL TEXT  

The aggressive low density lipoprotein lowering controversy
Forrester et al.
J Am Coll Cardiol 2000;36:1419-1425.
ABSTRACT | FULL TEXT  

Use of Simvastatin Treatment in Patients With Combined Hyperlipidemia in Clinical Practice
Vicari et al.
Arch Fam Med 2000;9:898-905.
ABSTRACT | FULL TEXT  

Strong and Significant Relationships Between Aggregation of Major Coronary Risk Factors and the Acceleration of Carotid Atherosclerosis in the General Population of a Japanese City: The Suita Study
Mannami et al.
Arch Intern Med 2000;160:2297-2303.
ABSTRACT | FULL TEXT  

Cholesterol-Lowering Therapy in Secondary Prevention: Remaining Issues
Grundy
J. Clin. Endocrinol. Metab. 2000;85:2092-2098.
FULL TEXT  

Coronary artery bypass surgery with arterial grafts in familial hypercholesterolemia
Kawasuji et al.
J. Thorac. Cardiovasc. Surg. 2000;119:1008-1013.
ABSTRACT | FULL TEXT  

Mild hypercholesterolemia and premature heart disease: do the national criteria underestimate disease risk?
Akosah et al.
J Am Coll Cardiol 2000;35:1178-1184.
ABSTRACT | FULL TEXT  

A Comparison of the Framingham Risk Index, Coronary Artery Calcification, and Culprit Plaque Morphology in Sudden Cardiac Death
Taylor et al.
Circulation 2000;101:1243-1248.
ABSTRACT | FULL TEXT  

Cholesterol-Lowering Treatment Is Associated With Improvement in Coronary Vascular Remodeling and Endothelial Function in Patients With Normal or Mildly Diseased Coronary Arteries
Hamasaki et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:737-743.
ABSTRACT | FULL TEXT  

Clinical Goals and Performance Measures for Cholesterol Management in Secondary Prevention of Coronary Heart Disease
Lee et al.
JAMA 2000;283:94-98.
ABSTRACT | FULL TEXT  

Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Medical Office Assessment : Writing Group I
Grundy et al.
Circulation 2000;101 :e3-e11.
FULL TEXT  

Reviews: Fluvastatin: Effects Beyond Cholesterol Lowering
Corsini
J CARDIOVASC PHARMACOL THER 2000;5:161-175.
ABSTRACT  

Walnuts Lower Serum Cholesterol in Japanese Men and Women
Iwamoto et al.
J. Nutr. 2000;130:171-176.
ABSTRACT | FULL TEXT  

Smoking and Atherosclerotic Cardiovascular Disease in Men With Low Levels of Serum Cholesterol: The Korea Medical Insurance Corporation Study
Jee et al.
JAMA 1999;282:2149-2155.
ABSTRACT | FULL TEXT